Minutes - Medication WG 2022-06-21
From Health Level 7 Belgium Wiki
Revision as of 10:02, 21 June 2022 by KarlienErauw (talk | contribs)
Attendees
- Annemieke Vergauwe
- Bart Decuypere
- Jean-Michel Polfliet
- Jens Penny
- José Costa Teixeira
- Karlien Erauw
- Pablo Christiaens
- Tom Henkens
Excused/Not present
- Anne Nerenhausen
- Bruno Casneuf
- Dieter Sauvillers
- Elhassan Baazizi
- Hanne Vuegen
- Jan Lenie
- Jean-Louis Maggetto
- Katrien Thorré
- Lars Vanreppelen
- Marc Buckens
- Nick Hermans
- Nils Devos
- Richard Francken
- Thomas Van Langendonck
- Tom De Backer
- Walter Bollaert
- Will van Norel
Agenda
- Future of medication scheme
Minutes
- Can we propose a publication of the medication scheme consisting of treatment lines
- Business rules of RIZIV are pending
- Examples are still missing
- Advantage of publishing : reaching out to stakeholders (* although before we said that the business rules should be part of the implementation guide )
- Medication treatments & medication treatment lines
- Prescription system could start using the medication treatment
- Medication statement : what is it ?
- Medication prescription
- Whenever you have a medication, you have a medication treatment
- How do we call it : medication line, medication statement line, medication treatment line ?
- however, can we go and publish the medication scheme ?
- goal is for prescribor applications to start using the medication treatment
- "The concept of "Medication Treatment Plan" of a patient represents the collection of all medication the patient was planned to take in the past, presently of in the future..."
- and looking at scheme p16 at treatment plan
- Looking at IHE Pharmacy supplement for treatment definition
- We need to add a glossary on medication, José will start on it as google doc or github
- we also need an aggregated diagram incl. reconciliation of doctors
Agenda items for next meeting
- Current state of profiles on medication view and treatment lines and how it all works at operational level
- Review glossary of terms &
- Collect feedback on contraindications
- Identifying business rules
Next meeting July 12 at 11AM
